The Hottest "Next Gen Crypto" in the World Right Now
Billion-Dollar Crypto Fund Sells Most of Its Bitcoin and Puts $380 Million Into a $2 Crypto.
Here's why…
Stanley J. Meresman, insider at Guardant Health

Stanley J. Meresman Insider Information

Director of Guardant Health
Stanley Meresman has served as a member of Guardant Health’s board of directors since May 2018. During the last ten years, Mr. Meresman has served on the boards of directors of various public and private companies, including service as chair of the audit committee for some of these companies. He currently serves on the board of directors, and as chair of the audit committee, of Snap, Inc. Previously, he served as a member of the board of directors, and chair of the audit committee, of Palo Alto Networks, Inc. from December 2014 to December 2018, LinkedIn Corporation from October 2010 to December 2016, Zynga Inc. from June 2011 to June 2015, Meru Networks, Inc. from September 2010 to May 2013, and Riverbed Technology, Inc. from March 2005 to May 2012. He also currently serves on the board, and as audit committee chair, of several private companies. From January 2004 to December 2004, Mr. Meresman was a Venture Partner with Technology Crossover Ventures, a private equity firm, and was General Partner and Chief Operating Officer of Technology Crossover Ventures from November 2001 to December 2003. During the four years before joining Technology Crossover Ventures, he was a private investor and board member and adviser to several technology companies. From May 1989 to May 1997, Mr. Meresman served as the Senior Vice President and Chief Financial Officer of Silicon Graphics, Inc. Mr. Meresman holds a B.S. degree in industrial engineering and operations research from the University of California, Berkeley and an M.B.A. degree from the Stanford Graduate School of Business.

What is Stanley J. Meresman's net worth?

The estimated net worth of Stanley J. Meresman is at least $1.15 million as of July 12th, 2021. Mr. Meresman owns 8,993 shares of Guardant Health stock worth more than $1,154,701 as of September 26th. This net worth evaluation does not reflect any other investments that Mr. Meresman may own. Learn More.

How do I contact Stanley J. Meresman?

The corporate mailing address for Mr. Meresman and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]

Has Stanley J. Meresman been buying or selling shares of Guardant Health?

During the past quarter, Stanley J. Meresman has sold $1,253,483.00 of Guardant Health stock. Most recently, Stanley J. Meresman sold 4,934 shares of the business's stock in a transaction on Friday, September 10th. The shares were sold at an average price of $129.78, for a transaction totalling $640,334.52.

Who are Guardant Health's active insiders?

Guardant Health's insider roster includes Ian Clark (Director), Helmy Eltoukhy (CEO), Samir Kaul (Director), and Stanley Meresman (Director).

Are insiders buying or selling shares of Guardant Health?

During the last year, insiders at the sold shares 47 times. They sold a total of 8,497,931 shares worth mmore than $939,868,849.09. The most recent insider tranaction occured on September, 10th when Stanley J Meresman Director bought 4,934 shares worth more than $640,334.52. Insiders at Guardant Health own 5.8 % of the company.

Information on this page was last updated on 9/10/2021.

Stanley J. Meresman Insider Trading History at Guardant Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Sell4,934$129.78$640,334.52View SEC Filing Icon  
7/12/2021Sell4,934$124.27$613,148.188,993View SEC Filing Icon  
5/10/2021Sell4,934$133.01$656,271.348,993View SEC Filing Icon  
4/12/2021Sell4,934$153.74$758,553.168,993View SEC Filing Icon  
2/10/2021Sell4,934$162.71$802,811.148,993View SEC Filing Icon  
1/11/2021Sell4,934$142.00$700,628.008,993View SEC Filing Icon  
12/10/2020Sell4,954$125.44$621,429.769,013View SEC Filing Icon  
11/10/2020Sell5,000$110.30$551,500.009,059View SEC Filing Icon  
10/12/2020Sell5,000$109.37$546,850.009,059View SEC Filing Icon  
9/10/2020Sell5,000$94.22$471,100.009,059View SEC Filing Icon  
8/10/2020Sell5,000$87.00$435,000.009,059View SEC Filing Icon  
7/10/2020Sell6,000$86.66$519,960.0010,059View SEC Filing Icon  
6/10/2020Sell6,000$80.59$483,540.007,302View SEC Filing Icon  
5/11/2020Sell6,500$86.50$562,250.007,802View SEC Filing Icon  
4/13/2020Sell9,500$66.62$632,890.0010,802View SEC Filing Icon  
2/13/2020Sell2,000$82.02$164,040.003,302View SEC Filing Icon  
1/15/2020Sell5,000$79.55$397,750.006,302View SEC Filing Icon  
12/12/2019Sell5,000$71.50$357,500.006,302View SEC Filing Icon  
11/21/2019Sell8,000$78.65$629,200.009,302View SEC Filing Icon  
11/19/2019Sell10,000$77.99$779,900.0011,302View SEC Filing Icon  
11/12/2019Sell10,000$70.97$709,700.0011,302View SEC Filing Icon  
See Full Table

Stanley J. Meresman Buying and Selling Activity at Guardant Health

This chart shows Stanley J Meresman's buying and selling at Guardant Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Guardant Health Company Overview

Guardant Health logo
Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.
Read More

Today's Range

Now: $128.40
Low: $126.40
High: $129.31

50 Day Range

MA: $118.18
Low: $98.77
High: $132.17

2 Week Range

Now: $128.40
Low: $96.66
High: $181.07


409,022 shs

Average Volume

946,103 shs

Market Capitalization

$13.01 billion

P/E Ratio


Dividend Yield



The Hottest "Next Gen Crypto" in the World Right Now
Billion-Dollar Crypto Fund Sells Most of Its Bitcoin and Puts $380 Million Into a $2 Crypto.
Here's why…